Marq Marquez

Servier Philippines is proud to support the May Measurement Month! Hypertension is a major contributor to serious health problems like stroke and heart disease.* Make blood pressure checks a regular part of your routine to detect any potential problems early. Whether you use a home monitor or visit your doctor, a few minutes can make a big difference in your health. ❤️ #BeTheCaptainOfYourLife by #CheckYourBloodPressure regularly 💪 #BecauseIsayso More information about hypertension 👉 https://lnkd.in/gVxRpgDa *World Health Organization. Hypertension: key facts. Published March 16, 2023. Accessed May 7,2024. https://lnkd.in/gA7fCKN 

18

How can a life sciences company support healthcare providers and patients along the care journey? Menarini partnered with Clarivate to enhance patient centricity for its established brands in the Asia Pacific region by generating fresh real-world evidence and effectively engaging physicians. By employing a validated patient journey mapping framework, they identified key gaps in care and opportunities for better patient engagement. Download the case study: https://lnkd.in/eiHTmXpz #PatientCare #DataAnalysis #RealWorldEvidence

29

Improving TB care, one health facility at a time. Discover how CareGo Health Suite empowers Dasmariñas CHO 1 to deliver more efficient, sustainable tuberculosis services.

5

Exciting news! Venus Remedies has achieved Marketing Authorization for key cancer treatment products across multiple countries. Our Paclitaxel 9300mg/50ml) is now approved in the Philippines, while Paclitaxel (100mg/16.7ml), Etoposide (100mg/5ml), and Bleomycin (15U) have received approval in Vietnam. Carboplatin (450mg/45ml) is now authorized in Kuwait, and Docetaxel is approved in Cyprus in (20mg, 80mg, and 160mg) formulations. We’re dedicated to enhancing patient care and access to quality treatments globally.   News coverage by Mr. Pradotya Kumar Saho, Ms. Maneesha Bhatt & Ms. Anmol Sharma, Reporters at Venus Pulse.   #MarketingAuthorization #CancerTreatment #Paclitaxel #Etoposide #Bleomycin #Carboplatin #Docetaxel #HealthcareInnovation #PatientCare #GlobalHealth #VenusRemedies #VenusRemediesLimited

27

🌍 World Diabetes Day is just around the corner on November 14th! Servier Philippines is excited to launch the #ActNowForDiabetes campaign to raise awareness and promote better health for those living with type 2 diabetes. This year, we’re focusing on the importance of maintaining an HbA1c level under 7%—the recommended target for most adults with type 2 diabetes. Why is this important? Keeping HbA1c levels under control can significantly reduce the risk of complications and improve overall quality of life. Let’s come together to support and educate our community about effective diabetes management. 💙 Take action today: • Share this post to spread the word. • Encourage regular HbA1c testing. • Promote healthy lifestyle choices. At Servier Philippines, we are dedicated to improving the lives of patients through innovative healthcare solutions and unwavering support for diabetes management. Join us in making a difference. Together, we can create a healthier future. To know more about diabetes: https://lnkd.in/dekUCPmH #WorldDiabetesDay #ActNowForDiabetes #KeepMoving #TakeYourMedicine #Adherence #T2D #DiabetesLife #TogetherForDiabetes

22

Boehringer Ingelheim Philippines, alongside the Philippine Alliance of Patient Organizations (PAPO), Dialysis PH, and Kidney Transplant Association of the Philippines, Inc. (KITAP), marked National Kidney Month with a crucial initiative ‘It Starts with U: Get CheCKD’ through an outdoor activation that highlights the impact of lifestyle choices on kidney health. For the company, the ‘It Starts with U: Get CheCKD’ initiative underscored the commitment to raise awareness and empower Filipinos in managing their kidney health, ensuring a healthier future for all. #healthadvocacy #campaign #philippines ------ -[Awards] MARKETECH APAC is launching its inaugural "Marketing Technology Awards" where we recognise the groundbreaking achievements in marketing technology, uniting the brands and tech organisations within the region’s marketing community. Learn how your brand can be a part of it by checking it more details HERE: https://bit.ly/3SVtoIa -[Conference] Learn about the latest trends, strategies, and technologies that converge to shape the future of customer marketing with our upcoming "Customer Marketing Asia 2024" conference in Singapore on September 10 [https://bit.ly/3YkKjIw]. -[Report] Discover the latest trends in business communication, and explore how mobile messaging channels are preferred by consumers to seek deeper connections with brands by checking out this report HERE: https://bit.ly/3RckF4z

7

🎗️🧬𝑨𝒅𝒗𝒂𝒏𝒄𝒊𝒏𝒈 𝑪𝒂𝒏𝒄𝒆𝒓 𝑪𝒂𝒓𝒆: 4𝒃𝒂𝒔𝒆𝑪𝒂𝒓𝒆 & 𝑳𝒊𝒏𝒌𝒊𝒏𝒈 𝑵𝒆𝒕𝒘𝒐𝒓𝒌 𝒇𝒐𝒓 𝑪𝒂𝒏𝒄𝒆𝒓 𝑺𝒆𝒓𝒗𝒊𝒄𝒆𝒔, 𝑰𝒏𝒄. or L!NCs™ #𝑷𝒉𝒊𝒍𝒊𝒑𝒑𝒊𝒏𝒆𝒔 𝑼𝒏𝒊𝒕𝒆 𝒇𝒐𝒓 𝑨𝒅𝒗𝒂𝒏𝒄𝒆𝒎𝒆𝒏𝒕𝒔 𝒊𝒏 𝑷𝒓𝒆𝒄𝒊𝒔𝒊𝒐𝒏 𝑶𝒏𝒄𝒐𝒍𝒐𝒈𝒚 ! 📣 We are excited to announce our #collaboration with the leading integrated network cancer #healthcare/#medical consultancy, L!NCs™ Philippines – a #partnership grounded on a shared mission to elevate cancer care and expand access to precision oncology across Southeast Asia. 👉 𝗧𝗵𝗲 𝗟!𝗡𝗖𝗦™ 𝗦𝘁𝗼𝗿𝘆:- Founded by four seasoned and dedicated medical #oncologists and a skilled liver #surgeon, each a leader in their fields who witnessed the challenges cancer patients faced especially in times of crisis, Linking Network for Cancer Services, Inc. or L!NCS™, was born out of necessity during the #pandemic. L!NCS™ is a company that is actively bridging gaps in cancer care by ‘LINC-ing’ (linking) key stakeholders from #healthcare providers, to #researchers, and #patient advocates – with a singular goal to #empower cancer patients, by improving access to precision oncology & personalized medicine thus improving survival outcomes for patients, their families, and their loved ones, through partnership with stakeholders sharing the same #mission. ⭐️ In a short span of 3 years, L!NCS™ has emerged as a trusted resource for #Filipino cancer patients navigating their journey, and 4baseCare is honored to support this mission. 🤝𝗧𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗢𝘂𝗿 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽 :- Together with L!NCS™, we at 4baseCare are harnessing the potential of Next Generation Sequencing (#NGS) making this technology available and accessible to Filipino cancer patients. By offering high quality #genomic profiling services, this partnership aims to guide #clinicians and #patients alike toward personalized treatments tailored to their unique biologic profiles, ensuring more effective and targeted cancer care. As 4baseCare expands its footprint across the region, this partnership reinforces our commitment to accessible, individualized treatment solutions for all. We look forward to working alongside L!NCS™ #Philippines to reshape the landscape of cancer care, turning the vision of personalized treatment into a reality for all patients. ⭐️ We salute the power of #collaboration, #innovation, and a shared mission for a future of #hope 🙏and #health 🌼! Catherine Teh Hitesh Goswami 4baseCare Kshitij Rishi Jojo Flores soumyaa gupta Yali Capital 4baseCare HR #4baseCare #LINCsPhilippines #PrecisionOncology #CancerCare #PersonalizedMedicine #NextGenSequencing #GenomicProfiling #CancerResearch #HealthcareInnovation #CancerSupport #PatientEmpowerment #OncologyPartnership #AsiaHealthcare #CancerTreatment #CollaborativeCare #InnovationInOncology #HealthcareAccess #FutureOfCancerCare #SoutheastAsia #Oncology #Philippines 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝗪𝗲 𝗕𝗲𝗮𝘁 𝗖𝗮𝗻𝗰𝗲𝗿

39

8 Komento

MaNaDr Mobile Health unveiled new, affordable pricing for their medical weight management program. This initiative aims to combat the rising obesity rates in Singapore and surrounding regions by making glucagon-like peptide-1 (GLP-1) receptor agonists more accessible. 💉🌍 Patients have access to the original, brand-name GLP-1 injections, ensuring the highest quality and proven results. With prices starting at just $10/day, MaNaDr's program is among the most competitively priced in the region. This strategic move is expected to drive significant adoption and generate meaningful incremental revenue starting in Q3 of this year. 📈 Join us in celebrating our client's commitment to improving healthcare affordability and accessibility in the APAC region! Read the full press here: https://lnkd.in/eT4sHemw #SkylineCCG #ClientSuccess #Telehealth #HealthcareInnovation #MedicalWeightLoss #GLP1 #MaNaDr #AffordableHealthcare #AsiaPacific #AIHealthcare Skyline is paid by $RYDE for IR services. Disclaimer 17(b) here: https://lnkd.in/dfxAN_h

16

2 Komento

🎀Empowering Choices in Breast Cancer Care🩺 In this insightful video, Dr. Chong Kwang Jeat, our Consultant Clinical Oncologist, delves into the 5 Pillars of Breast Cancer Treatment options. From surgery to immunotherapy, Dr. Chong highlights the importance of a multidisciplinary approach to ensure personalized and effective care. Understanding your options is key to making informed decisions. Join us in raising awareness and empowering those affected by breast cancer. Watch the full video to learn more about how we’re transforming care for better outcomes. Stay informed and stay empowered. 💗 #breastcancerawareness #breastcancer #breastcancertreatment #WomensHealth #mahkotamedicalcentre 𝘔𝘢𝘩𝘬𝘰𝘵𝘢 𝘔𝘦𝘥𝘪𝘤𝘢𝘭 𝘊𝘦𝘯𝘵𝘳𝘦 𝘪𝘴 𝘵𝘩𝘦 𝘍𝘪𝘳𝘴𝘵 𝘛𝘦𝘳𝘵𝘪𝘢𝘳𝘺 𝘗𝘳𝘪𝘷𝘢𝘵𝘦 𝘏𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘪𝘯 𝘔𝘢𝘭𝘢𝘺𝘴𝘪𝘢 𝘵𝘰 𝘰𝘣𝘵𝘢𝘪𝘯 𝘵𝘩𝘦 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘊𝘢𝘳𝘦 𝘗𝘳𝘰𝘨𝘳𝘢𝘮𝘮𝘦 𝘊𝘦𝘳𝘵𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯 (𝘊𝘊𝘗) 𝘧𝘰𝘳 𝘉𝘳𝘦𝘢𝘴𝘵 𝘊𝘢𝘯𝘤𝘦𝘳 𝘧𝘳𝘰𝘮 𝘵𝘩𝘦 𝘑𝘰𝘪𝘯𝘵 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘊𝘰𝘮𝘮𝘪𝘴𝘴𝘪𝘰𝘯 (𝘑𝘊𝘐). 𝘓𝘦𝘢𝘳𝘯 𝘮𝘰𝘳𝘦 𝘰𝘧 𝘰𝘶𝘳 𝘊𝘊𝘗𝘊 𝘱𝘳𝘰𝘨𝘳𝘢𝘮 𝘩𝘦𝘳𝘦: 014-4601 4247

30

The Asia Pacific region (APAC), like any large territory, encompasses a blend of well-established and early-stage economies, diverse healthcare systems, and differences in language, culture, politics, and technology adoption. APAC’s size and complexity has created new challenges and opportunities for the pharmaceutical industry as nations work together to meet the manufacturing needs for medical products. Read more in this Pharmaceutical Engineering® article, Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact: https://hubs.ly/Q02wW_qK0 #ISPE #pharmaceuticalengineering

6

Preventing dengue requires awareness and quick action. Our video shares valuable information on the early warning signs, risk factors of dengue. Watch and share the video with your loved ones to inform them about the various signs of dengue. For appointment 𝐝𝐢𝐚𝐥 +𝟗𝟏𝟖𝟑𝟑𝟔𝟗𝟎𝟎𝟒𝟒𝟖 #dengue #DengueSymptoms #denguefever #DengueAwareness #fever #irishospital #bestmultispecialityhospital #generalmedicine

3

We're excited to share that Universal Therapeutics has been honored at the Malaysia National Business Awards for our groundbreaking work in HIV testing and awareness! Honored with the esteemed Innovation Award - Health Products & Services, Universal Therapeutics is commended for AwarerHOME™ HIV oral self-test, the first of its kind made in Malaysia. In Malaysia, HIV remains a significant public health concern, with challenges such as stigma and limited testing access still prevalent. Universal Therapeutics' AwarerHOME™ represents a major advancement in addressing these issues by offering a convenient, discreet, and reliable HIV testing solution. By increasing the accuracy, reliability, and user-friendliness of HIV testing, this innovative kit aims to promote HIV awareness and motivate more individuals to undergo testing whenever they find themselves in situations with a high risk of exposure. Timely detection of HIV is essential for accessing treatment and care promptly, leading to improved health outcomes and reduced transmission of the virus. Acknowledged in the Innovation Award - Health Products & Services category at the Malaysia National Business Awards 2024, Universal Therapeutics continues to lead innovation and excellence in Malaysia's business arena. For more information about this product, visit iamawarer.com. You may also read the full article here:  https://lnkd.in/gvNe_8c3  ##ABRMYBusinessAwards #iAmAwarer #AwarerHOME #HIVAwareness #UniversalTherapeutics

2

Breaking Down Barriers: Advancing Equitable Access to Medicines in South Asia Join us at the AVPN South Asia Summit 2024 for the Keynote session exploring the challenges and solutions in ensuring affordable and accessible healthcare for all. Michelle Erwee, Global Head, Access to Medicines at Takeda Pharmaceuticals (Asia Pacific) will delve into the complex issues surrounding sustainable, equitable access to innovative medicines and vaccines worldwide. Discover how innovative policies, public-private partnerships, and technological advancements are transforming the healthcare landscape in South Asia. Key takeaways: ✅ Understanding the global gap in equitable access and how it relates to SouthEast Asia ✅ Takeda’s approach to broadening access to medicines ✅ The important role of Public Private Partnership Don't miss this opportunity to be part of the solution. Register now🔗: https://bit.ly/4eb5UIo #AVPN2024 #SouthAsiaSummit #SAS2024 #NewRealities #NewOpportunities #SocialInvestment #SustainableDevelopment #SeeYouInChennai #SouthAsiainChennai #Healthcare #AccessToMedicine

84

2 Komento

A heartfelt thank you to Boehringer Ingelheim for being one of our Sponsors for Pharmacy Week 2024! 🌟 Find out more on Chronic Kidney Disease from Boehringer Ingelheim! Chronic Kidney Disease (CKD) is silent – until it’s not. Today more than 500,000 Singaporeans are suffering from kidney disease, with diabetes and hypertension being the leading causes. Early detection and intervention of CKD are important in delaying the progression of CKD-related morbidity and mortality. This message is brought to you by Boehringer Ingelheim References: 1. National Kidney Foundation website, https://nkfs.org/ 2. Singapore Renal Registry Report 2021 3. Shlipak, Michael G et al. Kidney international vol. 99,1 (2021): 34-47. https://lnkd.in/gc27wzWP #PharmaceuticalSocietyofSingapore #PSS #PW2024 #justaskknowyourmedicines

3

🌏 Join us for our upcoming webinar, “Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities”, the second webinar from our "Trials Without Borders: Insights from Diverse Regions" series. 💡 In this insightful session, join our speakers, Phillip James Sayo and Marina Tang, as they share their expertise and insights on the regulatory frameworks, unique advantages, and promising opportunities for clinical trials in the dynamic landscapes of the Philippines and Malaysia. Discover why these regions are great choices for clinical research and learn strategies to navigate the complexities of conducting trials in diverse and vibrant settings. 📅 Date: July 30, 2024 (Tuesday) ⏰ Time: 15:00-16:00 (GMT+8) 🔗 Register here: https://lnkd.in/gQCA2bYr Don't miss this opportunity to gain valuable insights and explore the vast opportunities these regions offer. Register now to secure your spot and be part of this enriching webinar experience. #ClinicalTrials #HiRO #Philippines #Malaysia #TrialsWithoutBorders 

31

1 Komento

[Philippines] What is SmartCare/PS: http://t4.life/PSA the automated clinical protocol designed to accelerate weaning patients off the ventilator and to free up time for other tasks such as earlier mobilisation of the patients. Learn more about how SmartCare/PS can improve clinical outcomes and shorten ICU stay.

20

🛡️ A cancer diagnosis can change your life. In Southeast Asia, lung cancer is the second most common malignancy and the leading contributor to cancer-related fatalities*. On #WorldLungCancerDay, we are reminded of the tremendous bravery displayed by these patients. Remember, Cancer is a word, not a sentence. #LungCancerAwareness #Bravery #FightLungCancer #EarlyDetection #JNJ   *Reference: Global Cancer Observatory: Cancer Today. WHO South-Eastern Asia

22

1 Komento